Beverages - Alcoholic
Compare Stocks
5 / 10Stock Comparison
IBG vs WVVI vs MGPI vs SAM vs CRBP
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Wineries & Distilleries
Beverages - Wineries & Distilleries
Beverages - Alcoholic
Biotechnology
IBG vs WVVI vs MGPI vs SAM vs CRBP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Wineries & Distilleries | Beverages - Wineries & Distilleries | Beverages - Alcoholic | Biotechnology |
| Market Cap | $1M | $14M | $408M | $2.18B | $136M |
| Revenue (TTM) | $8M | $37M | $521M | $2.09B | $0.00 |
| Net Income (TTM) | $-6M | $-1M | $-240M | $-61M | $-79M |
| Gross Margin | 11.3% | 60.5% | 36.4% | 45.2% | — |
| Operating Margin | -71.3% | -2.4% | -51.2% | -3.8% | — |
| Forward P/E | — | — | 12.1x | 20.6x | — |
| Total Debt | $184K | $15.52B | $267M | $38M | $2M |
| Cash & Equiv. | $620K | $411M | $18M | $223M | $28M |
IBG vs WVVI vs MGPI vs SAM vs CRBP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 24 | May 26 | Return |
|---|---|---|---|
| Innovation Beverage… (IBG) | 100 | 1.7 | -98.3% |
| Willamette Valley V… (WVVI) | 100 | 83.2 | -16.8% |
| MGP Ingredients, In… (MGPI) | 100 | 22.9 | -77.1% |
| The Boston Beer Com… (SAM) | 100 | 70.1 | -29.9% |
| Corbus Pharmaceutic… (CRBP) | 100 | 52.7 | -47.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IBG vs WVVI vs MGPI vs SAM vs CRBP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, IBG doesn't own a clear edge in any measured category.
WVVI has the current edge in this matchup, primarily because of its strength in income & stability.
- Dividend streak 4 yrs, beta -0.25, yield 100.0%
- 100.0% yield, 4-year raise streak, vs MGPI's 2.5%, (3 stocks pay no dividend)
- -1.1% ROA vs IBG's -124.5%, ROIC -2.6% vs -87.3%
MGPI is the clearest fit if your priority is long-term compounding and defensive.
- -17.3% 10Y total return vs SAM's 32.0%
- Beta 0.63, yield 2.5%, current ratio 2.61x
- Better valuation composite
SAM is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 3.7%, EPS growth 95.5%, 3Y rev CAGR -0.0%
- Lower volatility, beta 0.29, Low D/E 4.5%, current ratio 1.65x
- 3.7% revenue growth vs WVVI's -100.0%
- Beta 0.29 vs CRBP's 1.36
CRBP ranks third and is worth considering specifically for quality and momentum.
- 3.3% margin vs IBG's -80.0%
- +77.3% vs IBG's -95.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.7% revenue growth vs WVVI's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 3.3% margin vs IBG's -80.0% | |
| Stability / Safety | Beta 0.29 vs CRBP's 1.36 | |
| Dividends | 100.0% yield, 4-year raise streak, vs MGPI's 2.5%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +77.3% vs IBG's -95.8% | |
| Efficiency (ROA) | -1.1% ROA vs IBG's -124.5%, ROIC -2.6% vs -87.3% |
IBG vs WVVI vs MGPI vs SAM vs CRBP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
IBG vs WVVI vs MGPI vs SAM vs CRBP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SAM leads in 1 of 6 categories
CRBP leads 1 • WVVI leads 1 • IBG leads 0 • MGPI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — WVVI and SAM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SAM and CRBP operate at a comparable scale, with $2.1B and $0 in trailing revenue. SAM is the more profitable business, keeping -2.9% of every revenue dollar as net income compared to IBG's -80.0%. On growth, SAM holds the edge at +1.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $8M | $37M | $521M | $2.1B | $0 |
| EBITDAEarnings before interest/tax | -$5M | $2M | -$249M | $14M | -$84M |
| Net IncomeAfter-tax profit | -$6M | -$1M | -$240M | -$61M | -$79M |
| Free Cash FlowCash after capex | -$3M | -$3M | $54M | $191M | -$64M |
| Gross MarginGross profit ÷ Revenue | +11.3% | +60.5% | +36.4% | +45.2% | — |
| Operating MarginEBIT ÷ Revenue | -71.3% | -2.4% | -51.2% | -3.8% | — |
| Net MarginNet income ÷ Revenue | -80.0% | -3.3% | -46.0% | -2.9% | — |
| FCF MarginFCF ÷ Revenue | -37.0% | -8.5% | +10.4% | +9.1% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -38.6% | -10.9% | -12.5% | +1.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +39.3% | -94.1% | -44.0% | -7.4% | -60.3% |
Valuation Metrics
Evenly matched — WVVI and MGPI each lead in 2 of 5 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1M | $14M | $408M | $2.2B | $136M |
| Enterprise ValueMkt cap + debt − cash | $966,549 | $15.1B | $656M | $2.0B | $109M |
| Trailing P/EPrice ÷ TTM EPS | -0.54x | -4.53x | -3.83x | 20.50x | -1.84x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 12.10x | 20.56x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — | 8.45x | — |
| Price / SalesMarket cap ÷ Revenue | 0.48x | — | 0.76x | 1.04x | — |
| Price / BookPrice ÷ Book value/share | 0.54x | 0.00x | 0.57x | 2.54x | 0.98x |
| Price / FCFMarket cap ÷ FCF | — | — | 5.37x | 10.09x | — |
Profitability & Efficiency
SAM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
WVVI delivers a -1.8% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-10 for IBG. CRBP carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MGPI's 0.37x. On the Piotroski fundamental quality scale (0–9), SAM scores 7/9 vs WVVI's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | -1.8% | -32.1% | -7.3% | -65.8% |
| ROA (TTM)Return on assets | -124.5% | -1.1% | -19.1% | -5.0% | -57.9% |
| ROICReturn on invested capital | -87.3% | -2.6% | -6.7% | +15.5% | -51.4% |
| ROCEReturn on capital employed | -155.2% | -3.1% | -8.1% | +14.8% | -58.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 1 | 4 | 7 | 2 |
| Debt / EquityFinancial leverage | 0.07x | 0.23x | 0.37x | 0.04x | 0.01x |
| Net DebtTotal debt minus cash | -$435,590 | $15.1B | $248M | -$186M | -$27M |
| Cash & Equiv.Liquid assets | $619,944 | $411M | $18M | $223M | $28M |
| Total DebtShort + long-term debt | $184,354 | $15.5B | $267M | $38M | $2M |
| Interest CoverageEBIT ÷ Interest expense | -13.53x | -0.69x | -40.23x | — | — |
Total Returns (Dividends Reinvested)
CRBP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MGPI five years ago would be worth $3,401 today (with dividends reinvested), compared to $116 for IBG. Over the past 12 months, CRBP leads with a +77.3% total return vs IBG's -95.8%. The 3-year compound annual growth rate (CAGR) favors CRBP at 2.4% vs IBG's -77.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -91.1% | -8.6% | -20.3% | +1.5% | +38.1% |
| 1-Year ReturnPast 12 months | -95.8% | -49.3% | -38.0% | -15.9% | +77.3% |
| 3-Year ReturnCumulative with dividends | -98.8% | -51.0% | -79.8% | -35.0% | +7.3% |
| 5-Year ReturnCumulative with dividends | -98.8% | -80.8% | -66.0% | -81.8% | -78.0% |
| 10-Year ReturnCumulative with dividends | -98.8% | -59.3% | -17.3% | +32.0% | -85.4% |
| CAGR (3Y)Annualised 3-year return | -77.4% | -21.2% | -41.3% | -13.4% | +2.4% |
Risk & Volatility
Evenly matched — WVVI and SAM each lead in 1 of 2 comparable metrics.
Risk & Volatility
WVVI is the less volatile stock with a -0.25 beta — it tends to amplify market swings less than CRBP's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SAM currently trades 76.7% from its 52-week high vs IBG's 2.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.13x | -0.25x | 0.63x | 0.29x | 1.36x |
| 52-Week HighHighest price in past year | $36.50 | $7.18 | $34.99 | $264.46 | $20.56 |
| 52-Week LowLowest price in past year | $0.84 | $2.49 | $16.45 | $185.34 | $6.10 |
| % of 52W HighCurrent price vs 52-week peak | +2.3% | +40.3% | +54.6% | +76.7% | +52.9% |
| RSI (14)Momentum oscillator 0–100 | 33.8 | 53.5 | 47.6 | 28.7 | 65.3 |
| Avg Volume (50D)Average daily shares traded | 790K | 3K | 279K | 199K | 262K |
Analyst Outlook
WVVI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MGPI as "Buy", SAM as "Hold", CRBP as "Buy". Consensus price targets imply 370.5% upside for CRBP (target: $51) vs 21.7% for SAM (target: $247). For income investors, WVVI offers the higher dividend yield at 100.00% vs MGPI's 2.53%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $29.00 | $246.86 | $51.14 |
| # AnalystsCovering analysts | — | — | 14 | 31 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +100.0% | +2.5% | — | — |
| Dividend StreakConsecutive years of raises | — | 4 | 2 | 0 | — |
| Dividend / ShareAnnual DPS | — | $194.20 | $0.48 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.3% | +9.4% | 0.0% |
SAM leads in 1 of 6 categories (Profitability & Efficiency). CRBP leads in 1 (Total Returns). 3 tied.
IBG vs WVVI vs MGPI vs SAM vs CRBP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IBG or WVVI or MGPI or SAM or CRBP a better buy right now?
For growth investors, The Boston Beer Company, Inc.
(SAM) is the stronger pick with 3. 7% revenue growth year-over-year, versus -100. 0% for Willamette Valley Vineyards, Inc. (WVVI). The Boston Beer Company, Inc. (SAM) offers the better valuation at 20. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate MGP Ingredients, Inc. (MGPI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IBG or WVVI or MGPI or SAM or CRBP?
On forward P/E, MGP Ingredients, Inc.
is actually cheaper at 12. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — IBG or WVVI or MGPI or SAM or CRBP?
Over the past 5 years, MGP Ingredients, Inc.
(MGPI) delivered a total return of -66. 0%, compared to -98. 8% for Innovation Beverage Group Limited (IBG). Over 10 years, the gap is even starker: SAM returned +32. 0% versus IBG's -98. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IBG or WVVI or MGPI or SAM or CRBP?
By beta (market sensitivity over 5 years), Willamette Valley Vineyards, Inc.
(WVVI) is the lower-risk stock at -0. 25β versus Corbus Pharmaceuticals Holdings, Inc. 's 1. 36β — meaning CRBP is approximately -642% more volatile than WVVI relative to the S&P 500. On balance sheet safety, Corbus Pharmaceuticals Holdings, Inc. (CRBP) carries a lower debt/equity ratio of 1% versus 37% for MGP Ingredients, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IBG or WVVI or MGPI or SAM or CRBP?
By revenue growth (latest reported year), The Boston Beer Company, Inc.
(SAM) is pulling ahead at 3. 7% versus -100. 0% for Willamette Valley Vineyards, Inc. (WVVI). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -419. 9% for MGP Ingredients, Inc.. Over a 3-year CAGR, SAM leads at -0. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IBG or WVVI or MGPI or SAM or CRBP?
The Boston Beer Company, Inc.
(SAM) is the more profitable company, earning 5. 2% net margin versus -87. 7% for Innovation Beverage Group Limited — meaning it keeps 5. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SAM leads at 6. 9% versus -88. 2% for IBG. At the gross margin level — before operating expenses — WVVI leads at 60. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IBG or WVVI or MGPI or SAM or CRBP more undervalued right now?
On forward earnings alone, MGP Ingredients, Inc.
(MGPI) trades at 12. 1x forward P/E versus 20. 6x for The Boston Beer Company, Inc. — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRBP: 370. 5% to $51. 14.
08Which pays a better dividend — IBG or WVVI or MGPI or SAM or CRBP?
In this comparison, WVVI (100.
0% yield), MGPI (2. 5% yield) pay a dividend. IBG, SAM, CRBP do not pay a meaningful dividend and should not be held primarily for income.
09Is IBG or WVVI or MGPI or SAM or CRBP better for a retirement portfolio?
For long-horizon retirement investors, Willamette Valley Vineyards, Inc.
(WVVI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 25), 100. 0% yield). Both have compounded well over 10 years (WVVI: -59. 3%, CRBP: -85. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IBG and WVVI and MGPI and SAM and CRBP?
These companies operate in different sectors (IBG (Consumer Defensive) and WVVI (Consumer Defensive) and MGPI (Consumer Defensive) and SAM (Consumer Defensive) and CRBP (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IBG is a small-cap quality compounder stock; WVVI is a small-cap income-oriented stock; MGPI is a small-cap quality compounder stock; SAM is a small-cap quality compounder stock; CRBP is a small-cap quality compounder stock. WVVI, MGPI pay a dividend while IBG, SAM, CRBP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.